FIELD: medicine.
SUBSTANCE: what is offered is a method for inhibition of malignant tumour metastasis and tumour cell migration by reducing a KRS cell level. That is ensured by using an expression vector comprising a promoter and a functionally bound polynucleotide coding antisemantic RNA or siRNA of KRS polynucleotide, or the KRS antibody.
EFFECT: invention provides effective inhibition of malignant tumour metastasis by inhibition of the KRS function responsible for intensified tumour cell migration and observed with KRS translocation into a membrane and reaction with a laminin receptor.
8 cl, 33 dwg, 1 tbl
Authors
Dates
2012-10-27—Published
2008-08-18—Filed